Cargando…
Angiomotin promotes renal epithelial and carcinoma cell proliferation by retaining the nuclear YAP
Renal cell carcinoma (RCC) is one of the common tumors in the urinary system without effective therapies. Angiomotin (Amot) can interact with Yes-associated protein (YAP) to either stimulate or inhibit YAP activity, playing a potential role in cell proliferation. However, the role of Amot in regulat...
Autores principales: | Lv, Meng, Li, Shuting, Luo, Changqin, Zhang, Xiaoman, Shen, Yanwei, Sui, YanXia, Wang, Fan, Wang, Xin, Yang, Jiao, Liu, Peijun, Yang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914293/ https://www.ncbi.nlm.nih.gov/pubmed/26848622 http://dx.doi.org/10.18632/oncotarget.7161 |
Ejemplares similares
-
Angiomotin Family Members: Oncogenes or Tumor Suppressors?
por: Lv, Meng, et al.
Publicado: (2017) -
Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer
por: Yang, Jiao, et al.
Publicado: (2019) -
Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011) -
Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway
por: Zeng, Hao, et al.
Publicado: (2016) -
Regulation of localization and function of the transcriptional co-activator YAP by angiomotin
por: Moleirinho, Susana, et al.
Publicado: (2017)